News
At 22, Daniel Cressy is making history as Louisiana’s first sickle cell gene therapy patient. The treatment could be a cure ...
Gene therapies hold immense promise for treating sight loss. These therapies use a modified, harmless virus to deliver ...
DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that ...
4d
MedPage Today on MSNFDA Restricts Gene Therapy Skysona Due to Blood Cancer RiskThe FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with ...
3don MSN
Vinay Prasad is returning to his role at the U.S. Food and Drug Administration to resume overseeing vaccine, gene therapy and ...
The Future of Cell and Gene Therapy: Navigating Innovation, Regulation, and Manufacturing Challenges
An interview with Philip Vanek, chief commercialization officer of the International Society for Cell & Gene Therapy (ISCT), ...
An expert discusses how community-based gene therapy administration has broadened treatment options for patients with ...
A research team headed by the University of Zurich has developed a powerful new method to precisely edit DNA by combining ...
The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, ...
Findings from St. Jude Children's Research Hospital demonstrate that virtual memory T cells, a specialized group of immune ...
With a strong launch underway for a bladder cancer gene therapy, Ferring Pharmaceuticals is finding the kind of commercial ...
DELRAY BEACH, FL / ACCESS Newswire / August 12, 2025 / Adolore BioTherapeutics, Inc., ("Company" or "Adolore") announced that Roy Clifford Levitt, MD, Clinical Professor at the University of Miami, Pr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results